Fighting cancer: The latest advances in immuno-oncology are revolutionizing therapy!

Fighting cancer: The latest advances in immuno-oncology are revolutionizing therapy!

Immuno-oncology has fundamentally transformed the treatment of cancer over the last decade. This innovative therapeutic approach uses the capabilities of the body's own immune system to attack cancer cells and significantly improve their quality of life. A press conference will take place in Vienna on January 29, 2025, in which leading experts such as Prim. Univ.-Prof. Dr. Wolfgang Hilbe and OA Dr. Maximilian Hochmair will report on the achievements and future developments in cancer medicine. In recent years, for example, the introduction of checkpoint inhibitors such as ipilimumab and nivolumab has significantly improved survival rates in patients with black skin cancer and advanced lung cancer krebsgesellschaft.de.

Progress and challenges

Despite all the progress, science faces major challenges. Many tumor types have developed mechanisms to evade detection by the immune system. Tumor-associated antigens (TAA) play a crucial role here and are needed to make cancer cells identifiable to the immune system. To overcome these challenges, research is currently focusing on combination therapies that combine conventional treatment methods with immunotherapy. Immunotherapy is considered a great hope for medicine and offers preliminary solutions to significantly increase the response rate in various cancers, as in the report by ots.at is explained in detail.

Immunotherapy has now found a permanent place in modern oncology. An important strategy is activating T cell therapy, in which the patient's T cells are genetically modified to specifically attack cancer cells. These innovative approaches can not only increase the chances of survival, but can also deliver valuable success in combination with other forms of therapy. The challenge remains to further decipher and understand the complex interactions between tumors and the immune system in order to advance the development of new, more effective treatment strategies.